KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other financing activities (2017 - 2025)

Elanco Animal Health's Other financing activities history spans 9 years, with the latest figure at -$17.0 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 383.33% year-over-year to -$17.0 million; the TTM value through Dec 2025 reached -$2.0 million, up 88.24%, while the annual FY2025 figure was -$2.0 million, 88.24% up from the prior year.
  • Other financing activities for Q4 2025 was -$17.0 million at Elanco Animal Health, down from $35.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $35.0 million in Q3 2025 and bottomed at -$20.0 million in Q1 2025.
  • The 5-year median for Other financing activities is -$7.5 million (2023), against an average of -$4.9 million.
  • The largest annual shift saw Other financing activities crashed 700.0% in 2024 before it surged 537.5% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$14.0 million in 2021, then soared by 107.14% to $1.0 million in 2022, then tumbled by 200.0% to -$1.0 million in 2023, then soared by 700.0% to $6.0 million in 2024, then plummeted by 383.33% to -$17.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Other financing activities are -$17.0 million (Q4 2025), $35.0 million (Q3 2025), and -$20.0 million (Q1 2025).